查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1600916

高流量氧气鼻管市场：按组件、适应症和最终用户划分 - 全球预测 2025-2030

High-flow Nasal Cannula Market by Component (Active Humidifier, Air Oxygen Blender, Heated Inspiratory Circuit), Indication (Acute Heart Failure, Acute Respiratory Failure, Bronchiectasis), End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 192 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

高流量氧气鼻管市场2023年估值为31.1亿美元，预计2024年将达33.8亿美元，复合年增长率为9.17%，预计到2030年将达到57.6亿美元。

高流量氧气鼻管(HFNC) 是医疗设备，旨在以比标准氧气鼻管更高的流量提供氧气疗法。该系统主要用于治疗患有呼吸系统疾病的患者，其中增强供氧和改善湿化非常重要。其范围包括监测氧气输送和改善重症加护环境中患者的舒适度，特别是呼吸困难且需要补充氧气的​​新生儿、儿童和成人患者。由于慢性阻塞性肺病、肺炎等呼吸系统疾病的盛行率不断上升，以及最近因 COVID-19 造成的激增，对 HFNC 系统的需求正在增加。应用范围包括医院、诊所和家庭环境，最终用户包括医疗机构和需要长期氧气疗法的患者。

主要市场统计
基准年[2023] 31.1亿美元
预测年份 [2024] 33.8亿美元
预测年份 [2030] 57.6亿美元
复合年增长率（%） 9.17%

医疗技术的进步、对以患者为中心的护理的日益重视、人口老龄化以及全球住院患者数量的增加推动了 HFNC 市场的发展，从而刺激了对高效呼吸支持设备的需求。最近的机会来自于新兴市场的认识和采用的提高、研发活动的增加以及人工智慧的整合以更准确地监测患者参数。然而，设备成本高、缺乏适当的报销政策以及替代治疗解决方案的存在等因素带来了挑战。新兴市场的预算限制和影响创新产品上市时间的监管障碍也可能阻碍市场成长。

创新包括小型化设备以远端医疗功能以及开发为个人化护理提供即时资料分析的智慧监控系统。将环保材料融入设备製造并探索可穿戴技术以实现无缝居家照护也提供了成长潜力。了解市场的动态本质，市场参与企业正在投资开发具有成本效益的先进 HFNC 系统，形成策略联盟以扩展到开拓的地区，并扩大他们的医疗保健。透过适应不断变化的医疗保健政策和患者需求，公司可以有效地利用 HFNC 市场即将出现的机会。

市场动态：快速发展的高流量氧气鼻管市场的关键市场洞察

高流量氧气鼻管市场正因供需的动态交互作用而转变。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时也能帮助消费行为及其对製造业的影响。

  • 市场驱动因素
    • 急性呼吸衰竭和睡眠呼吸中止症的盛行率增加
    • 增加 HFNC 在小儿支气管炎和肺炎治疗的使用
    • 居家照护中对非侵入性通气和持续性呼吸道正压的需求不断增加
  • 市场限制因素
    • 与传统插管相比高成本
  • 市场机会
    • 高流量氧气鼻管的技术进步
    • 支持商业化的有利法规结构
  • 市场挑战
    • 与不受监控地使用高流量氧气鼻管相关的方式和併发症

波特五力：驾驭高流量氧气鼻管市场的策略工具

波特的五力框架是了解高流量氧气鼻管市场竞争格局的关键工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解高流量氧气鼻管市场的外部影响

外部宏观环境因素在塑造高流量氧气鼻管市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解高流量氧气鼻管市场的竞争格局

高流量氧气鼻管市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵高流量氧气鼻管市场供应商的绩效评估

FPNV 定位矩阵是评估高流量氧气鼻管市场供应商的重要工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。四个象限清楚且准确地划分供应商，帮助使用者辨识最能满足其策略目标的合作伙伴和解决方案。

本报告提供了涵盖关键重点领域的全面市场分析：

1. 市场渗透率：对当前市场环境的详细回顾，包括行业主要企业的大量资料。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 急性呼吸衰竭和睡眠呼吸中止症的盛行率增加
      • 增加 HFNC 在小儿支气管炎和肺炎治疗的使用
      • 居家照护环境中对非侵入性通气和持续性呼吸道正压的需求不断增加
    • 抑制因素
      • 与传统插管相比相对昂贵
    • 机会
      • 高流量氧气鼻管的技术进步
      • 支持商业化的有利法规结构
    • 任务
      • 与无人监督使用高流量氧气鼻管相关的方式和併发症
  • 市场区隔分析
    • 组件：大量采用空气氧气混合器，提供精确调节氧气水平的关键能力
    • 最终用户：高流量氧气鼻管越来越多地在医院中使用，以支持广泛的患者和临床场景。
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境
  • 客户客製化

第六章高流量氧气鼻管市场：依组成部分

  • 主动加湿器
  • 空气氧气混合机
  • 加热进气迴路
  • 氧气鼻管

第七章依适应症分類的高流量氧气鼻管市场

  • 急性心臟衰竭
  • 急性呼吸衰竭
  • 支气管扩张
  • 一氧化碳毒性
  • 慢性阻塞性肺病

第八章高流量氧气鼻管市场：依最终用户分类

  • 门诊治疗中心
  • 医院
  • 长期照护中心

第九章北美及南美高流量氧气鼻管市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十章亚太地区高流量氧气鼻管市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章 欧洲、中东和非洲高流量氧气鼻管市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • 新的细支气管炎试验启动，为婴儿提供最佳呼吸支持
    • Teresa 的 Bonhawa Flow氧气疗法系统获得 FDA核准
    • Mercy Flight 为患有呼吸道疾病的高风险患者实施高流量氧气鼻管

公司名单

  • SunMed, LLC
  • Flexicare（Group）Limited
  • ResMed, Inc.
  • Armstrong Medical Limited
  • ICU Medical, Inc.
  • Fairmont Medical Products Pty Ltd.
  • Vapotherm, Inc.
  • Masimo Corporation
  • Dragerwerk AG & Co. KGaA
  • BMC Medical Co., Ltd.
  • Heka Medicals India Private Limited
  • Koninklijke Philips NV
  • Fisher & Paykel Healthcare Corporation Limited
  • Well Lead Medical Co., Ltd.
  • Vyaire Medical, Inc.
  • Narang Medical Limited
  • Teleflex Incorporated
  • MEKICS Co., Ltd.
  • Great Group Medical Co., Ltd.
  • Allied Medical Limited
  • Guangdong Pigeon Medical Apparatus Co.,Ltd.
  • Hamilton Medical AG
  • Synergy Intact Private Limited
  • nice Neotech Medical Systems Pvt. Ltd.
  • Sterimed Group
Product Code: MRR-437E9896A57C

The High-flow Nasal Cannula Market was valued at USD 3.11 billion in 2023, expected to reach USD 3.38 billion in 2024, and is projected to grow at a CAGR of 9.17%, to USD 5.76 billion by 2030.

The high-flow nasal cannula (HFNC) is a medical device designed for delivering oxygen therapy at a higher flow rate than standard nasal cannulas. This system is primarily used in the treatment of patients with respiratory diseases where enhanced oxygen delivery and improved humidification are critical. The scope includes monitoring oxygen delivery in critical care settings and improving patient comfort, particularly in neonatal, pediatric, and adult patients suffering from respiratory distress and requiring supplemental oxygen. The necessity for HFNC systems has grown due to an increased prevalence of respiratory conditions such as COPD, pneumonia, and recent surge due to COVID-19. Applications are broadly in hospitals, clinics, and home settings, with end-users including healthcare facilities and patients requiring long-term oxygen therapy.

KEY MARKET STATISTICS
Base Year [2023] USD 3.11 billion
Estimated Year [2024] USD 3.38 billion
Forecast Year [2030] USD 5.76 billion
CAGR (%) 9.17%

The HFNC market is being driven by advancements in medical technology, a heightened emphasis on patient-centric care, the aging population, and increased hospital admissions globally, which spur the demand for efficient breathing assistance devices. Recent opportunities arise from growing awareness and adoption in emerging markets, enhanced research and development activities, and the integration of artificial intelligence to monitor patient parameters more accurately. However, factors like high equipment costs, lack of adequate reimbursement policies, and the presence of alternative therapeutic solutions pose challenges. Market growth could be hampered by budget constraints in developing regions and regulatory hurdles impacting the time-to-market for innovative products.

Innovation scopes include the miniaturization of devices for improved portability, expanding telehealth capabilities, and the development of smart monitoring systems that deliver real-time data analytics for personalized care. Incorporating eco-friendly materials in device manufacturing and exploring wearable technologies for seamless home care also offer growth potential. Understanding the dynamic nature of the market, businesses should invest in creating cost-effective yet advanced HFNC systems, form strategic alliances to penetrate untapped regions, and actively participate in healthcare tech exhibitions to showcase innovation. By aligning with evolving healthcare policies and patient needs, companies can effectively harness upcoming opportunities in the HFNC market.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving High-flow Nasal Cannula Market

The High-flow Nasal Cannula Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing Prevalence of Acute Respiratory Failures and Sleep Apnea
    • Increasing Utilization of HFNC in the Treatment of Bronchitis and Pneumonia Among Children
    • Rising need for Non-Invasive Ventilation and Continuous Positive Airway Pressure in Home Care Settings
  • Market Restraints
    • Relatively High Cost Compared to Traditional Cannula
  • Market Opportunities
    • Technological Advancements in High-Flow Nasal Cannula
    • Favorable Regulatory Framework Supporting Commercialization
  • Market Challenges
    • Modalities and Complications Associated With Unmonitored Use of High-Flow Nasal Cannula

Porter's Five Forces: A Strategic Tool for Navigating the High-flow Nasal Cannula Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the High-flow Nasal Cannula Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the High-flow Nasal Cannula Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the High-flow Nasal Cannula Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the High-flow Nasal Cannula Market

A detailed market share analysis in the High-flow Nasal Cannula Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the High-flow Nasal Cannula Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the High-flow Nasal Cannula Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Key Company Profiles

The report delves into recent significant developments in the High-flow Nasal Cannula Market, highlighting leading vendors and their innovative profiles. These include SunMed, LLC, Flexicare (Group) Limited, ResMed, Inc., Armstrong Medical Limited, ICU Medical, Inc., Fairmont Medical Products Pty Ltd., Vapotherm, Inc., Masimo Corporation, Dragerwerk AG & Co. KGaA, BMC Medical Co., Ltd., Heka Medicals India Private Limited, Koninklijke Philips N.V., Fisher & Paykel Healthcare Corporation Limited, Well Lead Medical Co., Ltd., Vyaire Medical, Inc., Narang Medical Limited, Teleflex Incorporated, MEKICS Co., Ltd., Great Group Medical Co., Ltd., Allied Medical Limited, Guangdong Pigeon Medical Apparatus Co.,Ltd., Hamilton Medical AG, Synergy Intact Private Limited, nice Neotech Medical Systems Pvt. Ltd., and Sterimed Group.

Market Segmentation & Coverage

This research report categorizes the High-flow Nasal Cannula Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Component, market is studied across Active Humidifier, Air Oxygen Blender, Heated Inspiratory Circuit, and Nasal Cannula.
  • Based on Indication, market is studied across Acute Heart Failure, Acute Respiratory Failure, Bronchiectasis, Carbon Monoxide Toxicity, and Chronic Obstructive Pulmonary Disease.
  • Based on End User, market is studied across Ambulatory Care Centers, Hospitals, and Long-Term Care Centers.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing Prevalence of Acute Respiratory Failures and Sleep Apnea
      • 5.1.1.2. Increasing Utilization of HFNC in the Treatment of Bronchitis and Pneumonia Among Children
      • 5.1.1.3. Rising need for Non-Invasive Ventilation and Continuous Positive Airway Pressure in Home Care Settings
    • 5.1.2. Restraints
      • 5.1.2.1. Relatively High Cost Compared to Traditional Cannula
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological Advancements in High-Flow Nasal Cannula
      • 5.1.3.2. Favorable Regulatory Framework Supporting Commercialization
    • 5.1.4. Challenges
      • 5.1.4.1. Modalities and Complications Associated With Unmonitored Use of High-Flow Nasal Cannula
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Component: significant adoption of air oxygen blenders to provide critical functionality of precisely adjusting oxygen levels
    • 5.2.2. End User: Growing use of high-flow nasal cannula in hospitals for supporting a wide range of patients and clinical scenarios.
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental
  • 5.5. Client Customization

6. High-flow Nasal Cannula Market, by Component

  • 6.1. Introduction
  • 6.2. Active Humidifier
  • 6.3. Air Oxygen Blender
  • 6.4. Heated Inspiratory Circuit
  • 6.5. Nasal Cannula

7. High-flow Nasal Cannula Market, by Indication

  • 7.1. Introduction
  • 7.2. Acute Heart Failure
  • 7.3. Acute Respiratory Failure
  • 7.4. Bronchiectasis
  • 7.5. Carbon Monoxide Toxicity
  • 7.6. Chronic Obstructive Pulmonary Disease

8. High-flow Nasal Cannula Market, by End User

  • 8.1. Introduction
  • 8.2. Ambulatory Care Centers
  • 8.3. Hospitals
  • 8.4. Long-Term Care Centers

9. Americas High-flow Nasal Cannula Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific High-flow Nasal Cannula Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa High-flow Nasal Cannula Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. New Bronchiolitis Trial Launched to Seek The Best Breathing Support For Babies
    • 12.3.2. Telesair Secures FDA Nod For Bonhawa Flow Oxygen Therapy System
    • 12.3.3. Mercy Flights Implementing High-Flow Nasal Cannula for High-Risk Respiratory Illness

Companies Mentioned

  • 1. SunMed, LLC
  • 2. Flexicare (Group) Limited
  • 3. ResMed, Inc.
  • 4. Armstrong Medical Limited
  • 5. ICU Medical, Inc.
  • 6. Fairmont Medical Products Pty Ltd.
  • 7. Vapotherm, Inc.
  • 8. Masimo Corporation
  • 9. Dragerwerk AG & Co. KGaA
  • 10. BMC Medical Co., Ltd.
  • 11. Heka Medicals India Private Limited
  • 12. Koninklijke Philips N.V.
  • 13. Fisher & Paykel Healthcare Corporation Limited
  • 14. Well Lead Medical Co., Ltd.
  • 15. Vyaire Medical, Inc.
  • 16. Narang Medical Limited
  • 17. Teleflex Incorporated
  • 18. MEKICS Co., Ltd.
  • 19. Great Group Medical Co., Ltd.
  • 20. Allied Medical Limited
  • 21. Guangdong Pigeon Medical Apparatus Co.,Ltd.
  • 22. Hamilton Medical AG
  • 23. Synergy Intact Private Limited
  • 24. nice Neotech Medical Systems Pvt. Ltd.
  • 25. Sterimed Group

LIST OF FIGURES

  • FIGURE 1. HIGH-FLOW NASAL CANNULA MARKET RESEARCH PROCESS
  • FIGURE 2. HIGH-FLOW NASAL CANNULA MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES HIGH-FLOW NASAL CANNULA MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES HIGH-FLOW NASAL CANNULA MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. HIGH-FLOW NASAL CANNULA MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. HIGH-FLOW NASAL CANNULA MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. HIGH-FLOW NASAL CANNULA MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. HIGH-FLOW NASAL CANNULA MARKET DYNAMICS
  • TABLE 7. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY ACTIVE HUMIDIFIER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY AIR OXYGEN BLENDER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY HEATED INSPIRATORY CIRCUIT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY NASAL CANNULA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY ACUTE HEART FAILURE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY ACUTE RESPIRATORY FAILURE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY BRONCHIECTASIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY CARBON MONOXIDE TOXICITY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY AMBULATORY CARE CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY LONG-TERM CARE CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 26. ARGENTINA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 27. ARGENTINA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 29. BRAZIL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 30. BRAZIL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 31. BRAZIL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 32. CANADA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 33. CANADA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 34. CANADA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 35. MEXICO HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 36. MEXICO HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 37. MEXICO HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 38. UNITED STATES HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 39. UNITED STATES HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 40. UNITED STATES HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 41. UNITED STATES HIGH-FLOW NASAL CANNULA MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 42. ASIA-PACIFIC HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 43. ASIA-PACIFIC HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 44. ASIA-PACIFIC HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 45. ASIA-PACIFIC HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 46. AUSTRALIA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 47. AUSTRALIA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 48. AUSTRALIA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 49. CHINA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 50. CHINA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 51. CHINA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 52. INDIA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 53. INDIA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 54. INDIA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 55. INDONESIA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 56. INDONESIA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 57. INDONESIA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 58. JAPAN HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 59. JAPAN HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 60. JAPAN HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 61. MALAYSIA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 62. MALAYSIA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 63. MALAYSIA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 64. PHILIPPINES HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 65. PHILIPPINES HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 66. PHILIPPINES HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 67. SINGAPORE HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 68. SINGAPORE HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 69. SINGAPORE HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 70. SOUTH KOREA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 71. SOUTH KOREA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 72. SOUTH KOREA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 73. TAIWAN HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 74. TAIWAN HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 75. TAIWAN HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 76. THAILAND HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 77. THAILAND HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 78. THAILAND HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 79. VIETNAM HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 80. VIETNAM HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 81. VIETNAM HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 83. EUROPE, MIDDLE EAST & AFRICA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 84. EUROPE, MIDDLE EAST & AFRICA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 85. EUROPE, MIDDLE EAST & AFRICA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 86. DENMARK HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 87. DENMARK HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 88. DENMARK HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 89. EGYPT HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 90. EGYPT HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 91. EGYPT HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 92. FINLAND HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 93. FINLAND HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 94. FINLAND HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 95. FRANCE HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 96. FRANCE HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 97. FRANCE HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 98. GERMANY HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 99. GERMANY HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 100. GERMANY HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 101. ISRAEL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 102. ISRAEL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 103. ISRAEL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 104. ITALY HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 105. ITALY HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 106. ITALY HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 107. NETHERLANDS HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 108. NETHERLANDS HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 109. NETHERLANDS HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 110. NIGERIA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 111. NIGERIA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 112. NIGERIA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 113. NORWAY HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 114. NORWAY HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 115. NORWAY HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 116. POLAND HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 117. POLAND HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 118. POLAND HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 119. QATAR HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 120. QATAR HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 121. QATAR HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 122. RUSSIA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 123. RUSSIA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 124. RUSSIA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 125. SAUDI ARABIA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 126. SAUDI ARABIA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 127. SAUDI ARABIA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 128. SOUTH AFRICA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 129. SOUTH AFRICA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 130. SOUTH AFRICA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 131. SPAIN HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 132. SPAIN HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 133. SPAIN HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 134. SWEDEN HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 135. SWEDEN HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 136. SWEDEN HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 137. SWITZERLAND HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 138. SWITZERLAND HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 139. SWITZERLAND HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 140. TURKEY HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 141. TURKEY HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 142. TURKEY HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED ARAB EMIRATES HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED ARAB EMIRATES HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED ARAB EMIRATES HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 146. UNITED KINGDOM HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 147. UNITED KINGDOM HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 148. UNITED KINGDOM HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 149. HIGH-FLOW NASAL CANNULA MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 150. HIGH-FLOW NASAL CANNULA MARKET, FPNV POSITIONING MATRIX, 2023